MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PYPD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

PolyPid (PYPD) Ownership - Who owns PolyPid?

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
75
Web
https://www.polypid.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
98.17M
P/E Ratio
N/A
Total Cash
10.91M
Projected Growth
N/A
Total Debt
2.34M
Revenue
N/A
Risk (Beta)
1.07
Dividend Yield
N/A
Total Cash/Share
0.57
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PYPD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PYPD
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile
Details
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
75
Web
https://www.polypid.com